ArticleBMC research notes2025
Oropouche virus screening among acute febrile illness cases in Thailand: no evidence of circulation in arboviral-endemic regions.
Article in BMC research notes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oropouche virus (OROV) causes Oropouche fever, an acute febrile illness with clinical symptoms similar to other arboviral infections. Accurate laboratory confirmation is essential to differentiate OROV from other tropical diseases and avoid inappropriate treatment. While the biting midge is the primary vector, several species of mosquitoes such as Culex quinquefasciatus are considered urban vectors. To date, the presence of OROV in other arbovirus-endemic regions including Thailand remains unknown. Given the widespread distribution of Cx. quinquefasciatus in Thailand and increasing incidence of OROV in the Americas, investigating the circulation of OROV within the country is crucial. This study aimed to monitor the prevalence of OROV among patients with acute febrile illness who were clinically suspected of arbovirus infection in Thailand. We re-analyzed 1374 sera samples collected between 2018 and 2023 from acute febrile illness patients who had previously tested negative for arboviruses known to endemic in Thailand. Quantitative RT-PCR of these samples revealed no amplification signal of OROV RNA, indicating no evidence of OROV infection in this retrospective cohort study. Continuous comprehensive surveillance across diverse regions nationwide, coupled with investigations of potential vectors within the country, is necessary for monitoring any future introduction of OROV into Thailand.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.